News & Events
2-Year Data From a Prospective Randomized Controlled Trial of Minuteman
Spinal Simplicity Announces Publication of 2-Year Data From a Prospective Randomized Controlled Trial of Minuteman A groundbreaking prospective randomized controlled trial (RCT) comparing the safety and efficacy of Minuteman, a minimally invasive interspinous fusion device, with standard open...
Spinal Simplicity Announces FDA Clearance of Wolff’s Law Anterior Cervical Plate System
Spinal Simplicity Announces the FDA Clearance of Its Wolff’s Law Anterior Cervical Plate System Spinal Simplicity, a leading innovator in spinal healthcare solutions, proudly announces the FDA clearance of its Wolff’s Law Anterior Cervical Plate System. This achievement marks a significant step...
Spinal Simplicity announces FDA 510(k) Clearance of its Sacroiliac Joint System, the Patriot-SI Posterior Implant, With a Unique Hybrid Indication for Use
Spinal Simplicity announced the FDA 510(k) clearance of its Patriot-SI Posterior Implant System, designed for sacroiliac joint fusion in combination with the Liberty-SI lateral system. This clearance introduces a hybrid SI joint fusion construct, offering new treatment options for conditions such as sacroiliac disruptions and degenerative sacroiliitis.
Spinal Simplicity has a Banner Clinical Year Focusing on Research & Data for Its Flagship Product Minuteman®
Spinal Simplicity’s flagship Interspinous Fusion Device, Minuteman, has been the focus of three published studies this past year. These three groundbreaking studies resulted in showing Minuteman to be effective, safe with a high fusion rate, and comparing biomechanically to the gold standard of fusion – pedicle screws.
NANS 2024
2024 Annual NANS ConferenceIncredible weekend in Las Vegas at the North American Neuromodulation Society (NANS), where we showcased our groundbreaking products and cutting-edge technology. Heartfelt thanks to everyone who visited our booth to explore Minuteman and experience the all-new...
New Research Alert! Posterior Lateral Arthrodesis as a Treatment Option for Lumbar Spinal Stenosis: Safety and Early Clinical Outcomes
Overview: Lumbar Spinal Stenosis (LSS) impacts the quality of life for many patients, often leading to severe physical limitations. This latest study sheds light on a promising surgical treatment: Posterior Lateral Spinal Arthrodesis (PLSA). Study Insights: Participants: 191 patients,...
Spinal Simplicity announces 510(K) FDA Clearance of its novel Sacroiliac Joint System, the Liberty-SI Lateral Implant
Spinal Simplicity is pleased to announce the U.S. Food & Drug Administration (FDA) 510(K) clearance of the Spinal Simplicity Liberty-SI Lateral Implant System; a transfixing, lateral sacroiliac (SI) joint fusion system. The Liberty-SI Lateral Implant System is intended for sacroiliac joint...
ISPN Annual Conference Dubai 2023
Spinal Simplicity is thrilled to announce its participation in the prestigious Inaugural meeting of the International Society of Pain and Neuroscience (ISPN), set to take place at the Intercontinental Hotel in Dubai, UAE, on December 8 – 9, 2023.
Spinal Simplicity Hires Mark Farmer as VP of Education
Spinal Simplicity is proud to announce the hiring of Mark Farmer, VP of Education. With an impressive background in clinical expertise, sales acumen, and leadership within the Interventional Pain Market, Mark brings a wealth of experience to the Spinal Simplicity Team.
Spinal Simplicity Hires Dan Rogers as Vice President of Brand Development
Spinal Simplicity proudly welcomes Dan Rogers as the new Vice President of Brand Development, leveraging his vast experience to drive forward-thinking product and brand development. Dan is a strategic hire for us, providing leadership in both Product Development and Branding,” said Todd Moseley, CEO of Spinal Simplicity. “He has already shown in his first few days on the job what a tremendous asset he will be to our organization, leading our team in advancing technology to help more of our physician customers treat the right patient with the right therapy.”